Gb Sciences

GB Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical R & D development company recently published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation. It is now developing anti-inflammatory, cannabinoid-based...

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation. "The biopharmaceutical drug development firm's...